Samyang Holdings Corporation Biopharm division is a subsidiary specializing in biopharmaceutical business of Samyang Group, which was established in 1924, and is constantly tapping into the global market with a great emphasis on research and development activities, focusing on drug delivery system technology as well as biodegradable medical devices. With more than 20 years of experience in suture manufacturing and polymer technology, Samyang Holding's medical devices unit intends to further expand its portfolio of wound management products, devices for minimally invasive surgery, and medical aesthetics products. SYB Aesthetics is derived from combining art with technology. By bringing out your embedded beauty with Samyang's technology, SYB Aesthetics provides a helpful and safe solution to stay young and beautiful.